Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suheil Albert Atallah-Yunes

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Med (New York, N.Y.)|November 9, 2024
Dual epigenetic therapy plus chemotherapy in peripheral T cell lymphoma with T follicular helper phenotypeSuheil Albert Atallah-Yunes, Yucai Wang
Leukemia Research Reports|May 11, 2022
Current and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphomaSuheil Albert Atallah-Yunes, Michael J Robertson
Frontiers in Immunology|May 9, 2022
Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future PerspectivesSuheil Albert Atallah-Yunes, Michael J Robertson
Case Reports in Hematology|July 31, 2018
Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of IxazomibSuheil Albert Atallah-Yunes, Myat Han Soe
Leukemia & Lymphoma|January 5, 2024
Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trialsSuheil Albert Atallah-Yunes, Arushi Khurana, Matthew Maurer
The Lancet. Haematology|August 1, 2020
HIV-associated Burkitt lymphomaSuheil Albert Atallah-Yunes, Dermot J Murphy, Ariela Noy
Blood Reviews|July 1, 2019
Benign ethnic neutropeniaSuheil Albert Atallah-Yunes, Audrey Ready, Peter E Newburger
Blood Advances|August 14, 2025
Non-DLBCL Monomorphic and Hodgkin Lymphoma PTLD: Clinical Insights and Treatment StrategiesSuheil Albert Atallah-Yunes, Arushi Khurana, Thomas M Habermann
British Journal of Haematology|April 5, 2024
Targeted therapy in Burkitt lymphoma: Small molecule inhibitors under investigationSuheil Albert Atallah-Yunes, Thomas M Habermann, Arushi Khurana
British Journal of Haematology|March 22, 2023
Post-transplant lymphoproliferative disorder: Update on treatment and novel therapiesSuheil Albert Atallah-Yunes, Omar Salman, Michael J Robertson
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Med (New York, N.Y.)|November 9, 2024
Dual epigenetic therapy plus chemotherapy in peripheral T cell lymphoma with T follicular helper phenotypeSuheil Albert Atallah-Yunes, Yucai Wang
Leukemia Research Reports|May 11, 2022
Current and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphomaSuheil Albert Atallah-Yunes, Michael J Robertson
Frontiers in Immunology|May 9, 2022
Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future PerspectivesSuheil Albert Atallah-Yunes, Michael J Robertson
Case Reports in Hematology|July 31, 2018
Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of IxazomibSuheil Albert Atallah-Yunes, Myat Han Soe
Leukemia & Lymphoma|January 5, 2024
Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trialsSuheil Albert Atallah-Yunes, Arushi Khurana, Matthew Maurer
The Lancet. Haematology|August 1, 2020
HIV-associated Burkitt lymphomaSuheil Albert Atallah-Yunes, Dermot J Murphy, Ariela Noy
Blood Reviews|July 1, 2019
Benign ethnic neutropeniaSuheil Albert Atallah-Yunes, Audrey Ready, Peter E Newburger
Blood Advances|August 14, 2025
Non-DLBCL Monomorphic and Hodgkin Lymphoma PTLD: Clinical Insights and Treatment StrategiesSuheil Albert Atallah-Yunes, Arushi Khurana, Thomas M Habermann
British Journal of Haematology|April 5, 2024
Targeted therapy in Burkitt lymphoma: Small molecule inhibitors under investigationSuheil Albert Atallah-Yunes, Thomas M Habermann, Arushi Khurana
British Journal of Haematology|March 22, 2023
Post-transplant lymphoproliferative disorder: Update on treatment and novel therapiesSuheil Albert Atallah-Yunes, Omar Salman, Michael J Robertson
Pageof 3